| Bioactivity | α-Glucosidase-IN-27 (compound 8l) is an α-glucosidase inhibitor (IC50=25.78 μM). α-Glucosidase-IN-27 has the potential to study type 2 diabetes (D2M)[1]. |
| Target | IC50: 25.78 μM (α-Glucosidase). |
| Name | α-Glucosidase-IN-27 |
| Formula | C22H20N4O4S |
| Molar Mass | 436.48 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Abbasi MA, et al. Synthesis and Molecular Docking Studies of Novel Biheterocyclic Propanamides as Antidiabetic Agents Having Mild Cytotoxicity. ACS Omega. 2023 Jun 14;8(25):22899-22911. |